NEWS
 No recurrence in 9 kidney cancer patients given personalized vaccineAn early-stage clinical trial reported in Nature found that all nine high-risk kidney cancer patients who received a personalized vaccine after surgery showed no recurrence. The vaccine was designed specifically for each patient's tumor. This is a news summary compiled for the İyi Giden Şeyler newsletter — not the original article. The original article is at nazology.kusuguru.co.jp. Read the original article English (automatic translation) |